Hopman Mark sold BBNX
November 2, 2026 · Form 4 insider transaction
Hopman Mark sold 370 shares of Beta Bionics, Inc. at $16.90 per share, a transaction worth $6.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
370
Price
$16.90
Total value
$6.3K
InsiderHopman Mark
RoleOfficer
CompanyBeta Bionics, Inc. (BBNX)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 2, 2026
Filing dateNovember 4, 2026
Shares owned after54,143
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026.